by Adanna Williams, BestMSK Health Collaborative, Deputy Director
This week many of us are returning to work or starting our first week of 2022 having had a difficult Christmas period supporting and delivering services. I am mindful that the impact of focusing efforts to combat the Omicron variant has the potential to widen health inequalities. I have acknowledged how challenging this can be for those who need to access our services and those who are awaiting interventions.
In the BestMSK Healthcare Collaborative programme (an NHS England and Improvement programme), equality, diversity and inclusion (EDI) continues to be a key priority.…
Read more of this article
Hope on the horizon for immuno-suppressed/compromised individuals
We all look forward to 2022 with some trepidation. We don’t know how much impact Omicron will have on the NHS, the population, and our own families. 2021 was a year of challenge and also of incredible achievements. A vaccination programme which has now provided all adults with the opportunity for three doses, four in some cases; which has delivered boosters to three quarters of the eligible population; which delivered 1.6 million boosters in the final week of the year. None of this just happened.… 
Final update on the James Lind Alliance Psoriatic Arthritis Priority Setting Partnership
The application period for the third edition of the Brain Mind Pain Grant (2021-2022) started on 30 November 2021 and runs until the end of March 2022.
Psychosocial risks and work-related musculoskeletal disorders: exploring the links and prevention strategies
ARMA is pleased to welcome new associate member AbbVie to its membership.
NOA Webinar: COVID Orthopaedic Recovery: National and International recruitment
The Nuffield Foundation, in partnership with Versus Arthritis, has announced £4 million for new research funding to improve the social and economic wellbeing of people living with musculoskeletal conditions in the UK. Applicants should develop interdisciplinary proposals that can help identify, develop and enhance non-clinical policy and practice interventions.
The All Party Parliamentary Group (APPG) for Osteoporosis and Bone Health published a report into the long-standing postcode lottery in the NHS for osteoporosis care. The report highlights the scale of under-diagnosis, under-treatment and missed opportunities in the NHS, with a blueprint for change. Implementation of the blueprint in England and Wales could save the NHS around £287m over five years – a return on investment of around 3:1 – according to the Royal Osteoporosis Society (ROS), which has supported the Inquiry.…